Reference: Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials by Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine R Tuttle, Richard E Pratley and Vlado Perkovic, 25 November 2024, The Lancet Diabetes & Endocrinology
[5] GLP-1 upregulation can also directly enhance insulin signaling
Who Can Join
If a hormonal imbalance is identified, we will work with you to develop a personalized treatment plan to help regulate your cycles and address any other symptoms you may be experiencing, supporting your journey to optimal health and well-being
Many programs start cheap at the 0.25mg starter dose and escalate as you titrate up
It's important to note that FDA-approved semaglutide is only available in prefilled pens, not vials